The Beirne B. Carter Lecture in Immunology was established to bring a distinguished medical scientist each year to the UVA Health System.  In keeping with Mr. Carter’s vision, the scientist is chosen based on his or her research accomplishments contributing to the areas of basic and clinical immunology and to our understanding of human disease and its cure.

Past Beirne B. Carter Annual Lectures


Ralph Steinman, MD, PhD
Department of Cell Physiology and Immunology, Rockefeller University
The control of immunity and tolerance by dendritic cells


Gerald R. Crabtree, MD
Professor of Pathology and Developmental Biology, Stanford University School of Medicine
Converting graded signals to discrete developmental outcomes


Philippa Marrack, PhD
Investigator, Department of Immunology, Howard Hughes Medical Institute, National Jewish Medical and Research Center
T cell life, death and memory


Paul M. Allen, PhD
Robert L. Kroc Professor of Pathology & Immunology, Department of Pathology & Immunology, Washington University
Physiology of Tumor Rejection: Insights from a Transgenic Model


Craig Thompson, MD
Director, Madlyn Abramson Family Cancer Research Institute, University of Pennsylvania Cancer Center
Control of lymphocyte survival: implications for lymphocytes in health and disease


Roger M. Perlmutter, MD, PhD
Senior Vice President of Research, Merck & Co., Inc.
The LNK Family of Signal Transducing Molecules


Peter C. Doherty, PhD
St Jude’s Children Research Hospital
Immunity to a Persistent Gamma Herpesvirus


Klaus Rajewsky, MD
Institute for Genetics, University of Cologne
Genetic Approaches to the Study of Normal and Malignant B Cell Development


Richard Klauser, MD
Chief, Cell Biology abd Metabolism Branch, National Institutes of Child Health and Development
A Cell Biologist Looks at the T Cell Receptor


Leroy Hood, MD, PhD
University of Washington School of Medicine
T Cell Receptors: Molecular Recognition and Autoimmunity


Hugh O. McDevitt, MD
Stanford University School of Medicine
Peptide Interactions with Class II MHC Molecules in Experimental Allergic Encephalomyelitis